biogen has made a go of it.he challenge with bio similar is not just for biogen, but for any maker of these drugs. there's massive price erosion as more and more of them are launching. you see a decline in pricing power. so to really make this be a successful growth driver for biogen, you need to just continually launch and refresh the franchise. they sold their portion to jv. it was last year. now today we are hearing for the first time they are considering a strategic asset of that portion of their business altogether. down 10% year-over-year on the revenue basis and then a huge contributor to the top line. i think it's not an unreasonable level -- lever for them. i would argue that many that they are investigating, they will have to take advantage of it. kriti: speaking of levers, 30 seconds and on the spot, what's the bigger headwind right now? the regulatory process or potential m&a in the pipeline? marc: well if i can choose a third option, for the drugs to be effective they have to get cms and their contr

the top four gainers out of five are all biotech think of amgen, see jen, biogenic in gilead as well.en is raising $4 billion in debt and i saw getting more bullish in raising their target on biogen and see jen so far this week, what is biogen do they make therapies to treat alzheimer's and other cognitive disease, we know see jen does cancer therapy, i think it's a really interesting theme in a down market especially in the concerns of higher inflation and higher rates. >> they are real standouts. let's have a look at growth is it winning over value? stomach i would ask for somebody like you there is a different generational thinking. i'll tell you the younger investors will choose growth over value any day because of the long return. however, we know last year is a value play because of higher rates you have basically 400 basis points in one year in interest rates. growth this year have you looked at the speculative on profit tech names are up 100% in a.i.'s case look at the winners so far this week i told you about roku being up 70% so far this year. also draftkings you to talk to

>> good, gina, how are you >> caller: i'm a club member, i want to know more about biogen. >> there is fda and involved with getting approval from alzheimer's the plays went down except for biogen i think they are in the cat seat i don't think i'd ever say that. rich in new york, rich >> caller: hi, jim. >> hi, rich. >> caller: with the ceo leaving and the stock getting a nice bump, what should we do with union pacific? >> i think you should acrecept e fact the stock like disney will lose a lot maybe as much as ten points and then pounce why do i say that? union to sif pacific needs prec railroading and the stock is a great play i like canadian pacific north. let's go to carlos in new york, carlos >> caller: hey, jim, how is it doing? >> not bad at all. how about you? >> caller: doing great i would like to know -- >> good! >> caller: meta -- >> meta goes higher. i think mark zuckerberg is the most determined to make money for any ceo in the world he's cutting back expenses he's going to cut back not just operational but capital expenses and he's doing everything he can to right size th

sage therapeutics and biogen say that the fda could approve this medication by august. the national institute of health says around one in 7 women experienced postpartum depression after giving birth symptoms can include difficulty bonding with their baby, severe anxiety and panic attacks. >> still ahead, fewer than 24 hours after his state of the union address, president biden hit the road today touting his economic agenda. after the break, the issues lawmakers on both sides of the aisle hope biden plans to tackle. >> following a state of union address last night, president biden is taking his message on the road today. the president was in wisconsin battleground state touting his economic agenda. >> and reviews are split along party lines. washington correspondent reshad hudson joins us now live with the reaction. good evening. president biden, second state of the union address was definitely a lively event last night. at times the president engaged with those who booed at him. but today he's looking to turn the page by trying to sell his priorities to the american pe

biogen put up a strong quarter but the launch of the alzheimer's drug will way on 2023 profits.to see all of this digestion as investors right through so many macro and micro factors. dani: i can't get over that screen, department stores up 17%. thank you so much for the update there. bloomberg's abigail doolittle. it's 7:30 on the west coast. let's get to the start up. where we talk about the top tech stories from the bay area. we are watching elon musk. he spoke in dubai on twitter succession plans. >> i think i need to stabilize the organization and make sure it is in a financially healthy place in the roadmap is clearly laid out. i am guessing towards the end of this year it would be good timing to find someone else to run the company. i think it should be in a stable position at the end of this year. dani: joining us now is about low. i have a million questions based off those few seconds. he says late 2023 he thinks the company will be stable. how far from stable is twitter right now? is that target seems stable given that? ed: with him on musket everything's on a sliding

on the earnings front we get results from biogen, craft heintz, cisco, roku, aig, and more with thato the moves with zachary hill, horizon investments head of portfolio manage management and ross mayfield ross, let's start with you wu there something for everyone? >> i think so. if you're hawkish, you can take something away if you're dovish, you can take something away we know rnoknow realty is takiny on the other side, you know, goods inflation has been pretty su stu born it could be something that keeps the fed a little more hawkish than we'd like to see. >> we're seeing futures lower. yesterday, a mixed close on wall street it's almost as though the markets took this in its stride. does fed policy still matter at this point >> well, contessa, of course, fed policy still matters but i think the important thing for us as we look to this year, it's a lot less now that policy is better balanced they still have work to do, and certainly you've heard them talk about that over the last few weeks. but, you know, we're just not in that situation where we're going to have a better understa

number estimates gain 12.8% month-over-month 8/10 of a percent year-over-year earnings, kraft heinz biogen double beat on earnings and revenue, cisco watch after the close we will talk about that one tomorrow morning, as it puts up challenge for technical stocks mixed dow s&p 500 two day winning streaks s&p decline about one point, the nasdaq hi, by the way, it was up about 68, yields this morning look like take a look hat interest rate picture as federal reserve advice chairmen longtime dove lael brainard officially no foundations leaving for white house to become the top economic advisory succeeding brian deese, we had economic data, prices higher across the board ft 100 up 6 cac quarante up 84 dax higher by 38, uk latest cpi showed inflation is falling coming down, for third month in a row, in uk, in asia overnight red he across the board south korea biggest week spot deadline 1 1/2% others moving fractionally lower hong kong down 1 and a half percent as well in washington, still no word, no details with whatsoever on three unidentified objects, shot down, in the sky over the past weeke

seen over the last decade, is people have been focused on the abeta plaques what it goes after the biogenve breath broader approval, but it is only a beginning, i think the data shows it is not to be all, and end all, importantly you know plaques, are complicated and while people look at them, as important indicators of alzheimer's, 30% of people who are perfectly cognitively normal when they die, have plaques. so the plaques in an of themselves aren't what is going on, i think. and this sknt a cure for alzheimer's not close to a cure will have an effect on certain people. and going to be up to the physicians to figure out whether it is having an effect. maria: isn't an increasing number of people though going to get affected some numbers that we've spoken about are just daunting when you see the numbers of people who will face alzheimer's or some kind of dementia. >> absolutely, so, as we age, you know, alzheimer's was looked at early on as something that happened we called it presenile dementia, happened even people in 50s, now, as we watch, and there is no difference, in have what is g

pill to treat postpartum depression by august the new drug was developed by sage therapeutics and biogenent for adults with postpartum depression or major depressive disorder symptoms include difficulty bonding with the baby, loss of interest in activities in severe anxiety. one in seven women suffer from postpartum depression and that's a very common element, back to you. >> president biden finally adjusting china one hour into a state of the union address with a slight nod to the chinese by flight, watch this. >> are committed to work with china where we can advance american interest and benefit the world but make no mistake about it as we made clear last week of china trends or sovereignty we will act to protect our country, and we did. maria: after a week of the flight cannot enter collecting data the u.s. navy released the first images of the chinese by flight recovery efforts yesterday. once the pieces are collected they will be taken to the fbi lab in virginia to analyze the surveillance capabilities. joining us wall street journal asia technology author of surveillance state insi

earnings craft, biogenic for the opening bell cisco "after the bell" tonight we will preview coming uptocks close yesterday, the s&p 500 today we winning streak with the decline of 156 on the dow one half of 1% lower the nasdaq was up 68 the s&p 500 lower by one point a flat situation, yields the ten year treasury pulling back one in the third basis points as federal reserve vice chair and longtime dove while brainerd leaves the fed for the white house the president's top economic advisor succeeding brian deese of the director of economic counsel. european markets look like this. we had economic data in europe the latest cpi data showing inflation fell for a third straight month for the s&p 100 is a powerful point in the cat crown appears is up 77 and dax index higher by 53 in germany. overnight across-the-board south korea the weak spot. the others also negative. and then this no details on three unidentified object shot down over the past weekend new report showed u.s. intelligence officials were tracking the spy flight since it lifted off the southern coast of china. it still was ab

well which disease scattering thunder due to metal ha, ha, biogen after oil dependence, we're in the process of setting up a new dependence. me. so where do these absolutely essential resources come from? wire manufacturers, not communicating on their importance? perhaps because rare metals are extracted far from our cities far from sight. cobalt comes mainly from mines in the democratic republic of congo. australia, chilly, and bolivia have abundant lithium deposits. indonesia is a key producer of tangela, sir coney am or 10 thousands of mines and 4 continents are already producing hundreds of millions of tons of these resources . but one country in particular has colossal reserves of these strategic raw materials. china. the world's leading producer of rare metals, china extract 70 percent of one mineral that is particularly prized by green tech manufacturers. graphite we are in china's far north region in the province of hay longed young. here, the giant excavators brought down the mountain and laid bare the water tables to ensure our green future graphite as refined and antiquate

sage therapeutics and biogen say that the fda could approve this new medication as early as august. national institutes of health says that one in 7 women experience postpartum depression. and the symptoms can include difficulty bonding with the baby, severe anxiety and panic attacks. >> line says it's still awaiting a decision from the u.s. antitrust regulators in order to go through with its planned merger with jetblue. the airline says that within the next 30 days the department of justice will either block or allow that 3.8 billion dollar deal to proceed the merger. if it does go through would create the 5th largest airline and it's expected face several regulatory hurdles. as you can imagine. jetblue, though, says it does expect the deal to be completed some time at the beginning of next year. >> time now is 9.41. we're going take a quick break. we'll be back with more in a we'll be back with more in a minute. have heart failure and still experience unresolved symptoms? heart failure and seemingly unrelated symptoms like carpal tunnel syndrome... ...shortness of breath... ...ir

sage therapeutics and biogen say the fda could approve the new medication by august. the national institute of health says around one in 7 women experienced postpartum depression after giving birth symptoms can include difficulty bonding with their baby, severe anxiety and panic attacks. coming up, the family of gabby petito is releasing a troubling new image tied to her death. >> the latest details ahead. plus, lots of people are getting ready for sunday's big game. and sports betting is expected to see a big spike here. we explain. and some public police released new evidence they hope will crack a cold case murder. that video up next. >> in the east bay police released surveillance video showing a twenty-twenty deadly shooting in san pablo as kron four's philippe djegal learned police hope this new video will help them find the person responsible. lp>> 27 year-old sean tillis wa gunned down in san pablo just before 3 o'clock in the morning on june 12, 2020, the police department is releasing surveillance video of the ambush which happened in the back of an apartmen